Vaxcyte PCVX
NASDAQ PCVX
$56.48 +0.43 (+0.77%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vaxcyte (PCVX) Non Operating Investment Income (2024)

Updated

Vaxcyte (PCVX) posted Non Operating Investment Income of $1,000 for Q3 2024, down 96.3% from the prior quarter.

Analysis

Vaxcyte (PCVX) Non Operating Investment Income (2024) Analysis & Trends

For the trailing twelve months through Sep 30, 2024, Non Operating Investment Income at Vaxcyte was $50,000; for FY2022, it was -$44,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Vaxcyte 8.18 Bn 8.18 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 1,000.00
Jun 30, 2024 27,000.00
Mar 31, 2024 22,000.00
API Access

Vaxcyte Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=PCVX&period=max&api_key=YOUR_API_KEY